Objective Bronchoscopy using radial-endobronchial ultrasound (R-EBUS) and virtual bronchoscopic navigation (VBN) is a promising method for diagnosing peripheral pulmonary lesions. We previously performed a randomized comparative trial (RCT) (i.e., VBN combined with EBUS RCT) involving patients with 30-mm or smaller peripheral pulmonary lesions and found that the addition of VBN to R-EBUS improved the diagnostic yield. In the present study, we performed a retrospective subanalysis in order to identify patients for whom VBN is useful. Methods The per-protocol population (194 cases) of the VBN combined with EBUS RCT was divided into subgroups based on the lesion size, lung lobe containing the lesion, lesion location, presence or absence of involved bronchi (bronchus sign) on thin-section CT and whether the lesion was detected on posterioranterior (P-A) radiographs. The difference in the diagnostic yield between the VBN-assisted (VBNA) and non-VBN-assisted (NVBNA) groups was investigated. Results Within the bronchus sign-positive subgroup, the diagnostic yield in the VBNA and NVBNA groups was 94.4% (68/72) and 77.8% (56/72), respectively, showing a significantly higher yield in the VBNA group (p=0.004; odds ratio: 4.9). The yield was particularly high for lesions smaller than 20 mm (94.6% vs. 70.7%; p=0.006), lesions located in the peripheral third of the lung field (95.1% vs. 71.4%; p=0.005) and lesions invisible on P-A radiographs (90.0% vs. 41.7%; p=0.026). Conclusion VBN improves the diagnostic yield when combined with R-EBUS to assess lesions exhibiting involved bronchi on CT images.
Introduction
The widespread use of computed tomography (CT) has increased the detection rate of peripheral pulmonary lesions. However, many of these lesions are benign and thus detecting early lung cancer in patients with such lesions is crucial (1) . Peripheral pulmonary lesions are definitively diagnosed using surgical biopsies, transthoracic needle aspiration (TTNA) and/or transbronchial biopsies (2) . Bronchoscopy in particular has the advantage of having less complications, although its diagnostic yield is insufficient (3) . The American College of Chest Physicians (ACCP) guidelines recommend the use of radial endobronchial ultrasound (R-EBUS) for the bronchoscopic diagnosis of peripheral pulmonary lesions when appropriate devices and a skilled operator are available (3) . R-EBUS identifies lesions and sampling sites in real time using a radial-type ultrasound probe. Employing this method, biopsies may be applied repeatedly at the same site with the concomitant use of a guide sheath (GS) (4) . In a previous meta-analysis, the pooled sensitivity and specificity of R-EBUS for the detection of lung cancer in peripheral pulmonary lesions were 73% [95% confidence interval (CI): 70-76%] and 100% (95% CI: 99-100%), respectively (5). However, some lesions cannot be reached with the radial probe because the EBUS system does not include a navigation device (6, 7) .
Virtual bronchoscopic navigation (VBN) is a method in which virtual bronchoscopy (VB) images of the bronchial path to the peripheral lesion are produced and used as a guide to navigate the bronchoscope (8, 9) . In order to confirm the arrival of the bronchoscope at the lesion site, it is necessary to combine VBN with another procedure. For instance, the combination of VBN and EBUS-GS shows a high diagnostic yield of 63.3-84.4% for peripheral pulmonary lesions and 44.4-75.9% for 20-mm or smaller lesions (10) (11) (12) (13) (14) . We also previously demonstrated in a multicenter randomized comparative trial (RCT) that the addition of VBN to EBUS-GS significantly improves the diagnostic yield and shortens the examination time (VBN combined with EBUS RCT) (13) . Briefly, patients with 30-mm or smaller peripheral pulmonary lesions suspected to be lung cancer were randomly divided into two groups. In the VBNassisted (VBNA) group, a thin bronchoscope was guided to the lesion using a VBN system, by referring to the axial CT images in the non-VBN-assisted (NVBNA) group, followed by a biopsy. The diagnostic yield in the VBNA group according to the per-protocol analysis was 80.8%, being significantly higher than that (67.4%) observed in the NVBNA group (p=0.032). Meanwhile, the diagnostic yield was 75.9% vs. 59.3% for <20-mm lesions (p=0.056) and 87.8% vs. 80.6% for 20-30-mm lesions (p=0.382) in the VBNA and NVBNA groups, respectively.
Since VBN requires the use of thin-section CT under conditions recommended for the system, problems involving additional costs and increased exposure arise in cases requiring repeat CT images. Accordingly, the application of VBN in medical practice necessitates patient selection. In the present study, we performed a subanalysis of an RCT of VBN combined with EBUS (13) in order to identify patients for whom the addition of VBN to R-EBUS is useful.
Materials and Methods
Data from the per-protocol population (194 cases) of the VBN combined with EBUS RCT (13) that included all randomized patients undergoing planned bronchoscopic procedures for peripheral lesions were statistically analyzed. Two pulmonologists who were not informed of the diagnostic results individually evaluated the lesion size, lung lobe containing the lesion, lesion location and presence or absence of involved bronchi (bronchus sign) (15) on thin-section CT images (slice thickness: 0.5-1 mm) used for bronchoscopy and determined whether the lesion was detected on posterior-anterior (P-A) radiographs. The location of the lesion was classified into central, intermediate and peripheral thirds according to the distance from the hilum based on the study of Baaklini and coworkers (16) . When the findings of the two pulmonologists were inconsistent, a third pulmonologist made the final judgment. The difference in the diagnostic yield between the VBNA and NVBNA groups was investigated for each item. The institutional ethics committee approved the study.
Statistical analysis
Dichotomous variables were analyzed using the Pearson χ2 test or Fisher's exact test. All p-values were two-sided. A p value of <0.05 was considered to indicate a statistically significant difference. The Bonferroni correction was not used to address the multiplicity problem in this study. All data were statistically analyzed using the IBM SPSS Statistics software program, version 19 (SPSS, Chicago, USA).
Results
Regarding the presence or absence of the bronchus sign, within the bronchus sign-positive subgroup, the diagnostic yield in the VBNA and NVBNA groups was 94.4% and 77.8%, respectively, showing a significantly higher yield in the VBNA group [p=0.004; odds ratio: 4.9; 95% confidence interval (CI): 1.5-15.4]. In the bronchus sign-negative subgroup, the diagnostic yield was not significantly different between the two groups. In addition, there were no significant differences in the diagnostic yield between the VBNA and NVBNA groups in any of the subgroups in terms of the lung lobe containing the lesion, lesion location and whether the lesion was detected on P-A radiographs (Table 1) .
Within the bronchus sign-positive subgroup, the diagnostic yield was significantly higher in the VBNA group among the patients with a lesion size of <20 mm (94.6% vs. 70.7%; p=0.006; odds ratio: 7.2; 95% CI: 1.5-35.0), lesions located in the peripheral third of the lung field (95.1% vs. 71.4%; p=0.005; odds ratio: 7.8; 95% CI: 1.6-38.6) and invisible lesions on P-A radiographs (90.0% vs. 41.7%; p= 0.026; odds ratio: 12.6; 95% CI: 1.2-133.9). There were no significant differences in the diagnostic yield between the two groups for any other items ( Table 2) .
Discussion
We determined whether VBN improves the diagnostic yield of R-EBUS for peripheral pulmonary lesions with involved bronchi. As EBUS is recommended according to the 2013 ACCP guidelines, an increase in the number of cases in which this procedure is applied is expected. However, the characteristics of patients for whom combination treatment with VBN is useful have not been thoroughly investigated. Hence, to the best of our knowledge, this study is the first subclass analysis to show that VBN improves the diagnostic yield when combined with R-EBUS, particularly for lesions exhibiting involved bronchi. Lesions showing an involved bronchus were detected in 144 cases, comprising more than 70% of all patients, which may account for the significant improvement in the diagnostic yield observed in the total VBNA group (13) . The diagnostic yield of conventional bronchoscopy for lesions showing no involved bronchi is low (3). In such cases, transbronchial needle aspiration is reportedly useful (17) ; however, this procedure was not performed in the current study. Since VBN guides the bronchoscope to the lesion using virtual images of the bronchial route, the routes for lesions without involved bronchi may not have been accurately prepared, thus preventing VBN from achieving any effect. The VBN system is capable of displaying the site and direction of transbronchial needle puncture. At present, TTNA and surgical biopsies are indicated for lesions involving no bronchus, although it is necessary to investigate the effectiveness of transbronchial needle aspiration (TBNA) using VBN.
In this study, the subanalysis clarified that combination treatment with VBN improves the diagnostic yield for lesions showing involved bronchi on thin-section CT images, particularly lesions smaller than 20 mm and those located in the peripheral third of the lung field or invisible on P-A radiographs. Since the diagnostic yield in these three subgroups on conventional bronchoscopy is reportedly low (3, 16) , VBN is deemed useful for assessing these le-sions. VBN requires the application of thin-slice CT, and repeat CT examinations may be necessary depending on the patient's condition. By limiting the use of VBN to subgroups for whom the diagnostic yield is improved with VBN according to the subanalysis, overall medical expenses can be minimized.
The pooled sensitivity of TTNA for the diagnosis of peripheral bronchogenic carcinoma is reported to be 90% (95% CI, 88-91%) (3), while Ohno et al. reported that the diagnostic yield of CT-guided TTNA for 20-mm or smaller lesions is 77.5% (18) . TTNA is generally performed in such cases due to its high diagnostic yield. However, the diagnostic yield for lesions showing involved bronchi is significantly improved with VBN, reaching 94.4% in the current subanalysis. In particular, the diagnostic yields for lesions smaller than 20 mm and those located in the peripheral third of the lungs and invisible on P-A radiographs were high (94.6%, 95.1% and 90.0%, respectively), being comparable with that obtained using TTNA. Regarding the TTNAinduced complication rate, the incidence of pneumothorax requiring drainage is 6.6% (95% CI: 6.0-7.2%), while that including cases not requiring drainage is 15.0% (95% CI: 14.0-16.0%), showing high incidences in both circumstances (19). Meanwhile, the incidence of hemorrhage is 1.0% (95% CI: 0.9-1.2%), and 17.8% of such patients require blood transfusions (19). In contrast, the bronchoscopyinduced complication rate is low. Furthermore, no complications directly caused by VBN have been reported, suggesting that bronchoscopy using VBN combined with EBUS is safer than TTNA. Further investigations using RCTs are needed to determine the positions of the two procedures (TTNA and bronchoscopy using VBN combined with EBUS) for the diagnosis of peripheral pulmonary lesions.
This study is associated with some limitations. As the analysis was retrospective, the evidence level is lower than that of prospective studies. In addition, the possibility of biased findings cannot be excluded, and it is possible that significant differences were not detected owing to the weak statistical power of the subanalysis as a result of the small number of cases. Furthermore, confounding factors for each item may have affected the findings, and the most important item for increasing the diagnostic yield using VBN was unclear. In order to clarify these issues, it is necessary to perform a meta-analysis and RCT of VBN, focusing on the subgroups in whom VBN is suggested to be useful.
In conclusion, VBN improves the diagnostic yield when combined with R-EBUS for lesions showing involved bronchi on CT images. As EBUS is recommended according to the ACCP guidelines, the number of cases in which this technique is applied may increase. VBN should be actively used to assess lesions exhibiting involved bronchi, particularly lesions smaller than 20 mm and those located in the peripheral third of the lung field and/or invisible on P-A radiographs due to the high diagnostic yield of this modality.
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